RJ Kreitman, E Arons… - Leukemia & …, 2011 - informahealthcare.com ... Recombinant immunotoxins and other therapies for relapsed/refractory hairycellleukemia. June 2011, Vol. 52, No. ... Need for alternative approaches in hairycellleukemia, Section: Choose. ... Related articles
TA Summers, ES Jaffe - Leukemia & Lymphoma, 2011 - informahealthcare.com ...Hairycellleukemia diagnostic criteria and differential diagnosis. Posted online on March 21, 2011. ... Next section. Hairycellleukemia (HCL) is a disease with distinctive clinical findings, as well as a unique morphology and immunophenotype. ... Related articles - All 2 versions
T Robak - Cancer treatment reviews, 2011 - Elsevier ... Anti-Tumor Treatment. Hairy-cellleukemia variant: Recent view on diagnosis, biology and treatment star, open. ...Hairy-cellleukemia variant (HCl-V) is a district clinico-pathological entity with intermediate features between classical HCl (HCl-C) and B-cell prolymphocytic leukemia. ... Cited by 6 - Related articles - All 4 versions
P Noel - Leukemia & lymphoma, 2011 - informahealthcare.com ... Definition of remission, minimal residual disease, and relapse in hairycellleukemia bone marrow biopsy histology and immunohistology specimens. ... Phase II trial of recombinant immunotoxin RFB4(dsFV)-PE38 (BL22) in patients with hairycellleukemia. ... Related articles - All 3 versions
F Ravandi, S O'Brien, J Jorgensen, S Pierce… - Blood, 2011 - ncbi.nlm.nih.gov ... Phase II study of cladribine followed by rituximab in patients with hairycellleukemia. ... We conducted this study to determine the feasibility and safety of caldribine followed by rituximab in patients with hairycellleukemia including the variant form (HCLv). ...
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
